Crosslinking treatment of progressive keratoconus: new hope

Purpose of review A new method has been introduced for the treatment of progressive keratoconus using collagen crosslinking by the photosensitzer riboflavin and ultraviolet A-light. Biomechanical measurements have shown an impressive increase in corneal rigidity of 328.9% in human corneas after crosslinking. Recent findings The 3 and 5-year results of the Dresden clinical study have shown that in all treated 60 eyes the progression of keratoconus was at least stopped (‘freezing’). In 31 eyes there also was a slight reversal and flattening of the keratoconus by up to 2.87 diopters. Best corrected visual acuity improved slightly by 1.4 lines. So far, over 150 keratoconus patients have received crosslinking treatment in Dresden. Laboratory studies have revealed that the maximum effect of the treatment is in the anterior 300 μm of the cornea. As for the corneal endothelium, a cytotoxic level for endothelium was found to be 0.36 mW/cm2 which would be reached in human corneas with a stromal thickness of less than 400 μm. Summary Collagen crosslinking by the photosensitzer riboflavin and ultraviolet A-light is an effective means for stabilizing the cornea in keratoconus. Collagen crosslinking might become the standard therapy for progressive keratoconus in the future diminishing significantly the need for corneal transplantation. Preoperative pachymetry and individual control of the ultraviolet A-irradiance before each treatment are mandatory. The treatment parameters must not be varied.

[1]  T. Seiler,et al.  [Treatment of keratoconus by collagen cross linking]. , 2003, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[2]  Hsing-Wen Sung,et al.  Crosslinking of biological tissues using genipin and/or carbodiimide. , 2003, Journal of biomedical materials research. Part A.

[3]  T. Avitabile,et al.  Evaluation of central and peripheral corneal thickness with ultrasound biomicroscopy in normal and keratoconic eyes. , 1997, Cornea.

[4]  Eberhard Spoerl,et al.  Biomechanical evidence of the distribution of cross‐links in corneastreated with riboflavin and ultraviolet A light , 2006, Journal of cataract and refractive surgery.

[5]  M. Jankov,et al.  Riboflavin / Ultraviolet A–Induced Collagen Cross–Linking in the Management of Keratoconus , 2005 .

[6]  T. Seiler,et al.  Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro , 2004, Eye.

[7]  L. Bauernfeind.  Strengthening a , 1975 .

[8]  R. Nagaraj,et al.  Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. , 1995, Biochemical and biophysical research communications.

[9]  G. Wollensak,et al.  Corneal Endothelial Cytotoxicity of Riboflavin/UVA Treatment in vitro , 2003, Ophthalmic Research.

[10]  J. Faulborn,et al.  Diabetic Vitreopathy – Findings Using the Celloidin Embedding Technique , 1998, Ophthalmologica.

[11]  Theo Seiler,et al.  Keratocyte Apoptosis After Corneal Collagen Cross-linking Using Riboflavin/UVA Treatment , 2004, Cornea.

[12]  D G Pitts,et al.  Ocular effects of ultraviolet radiation from 295 to 365 nm. , 1977, Investigative ophthalmology & visual science.

[13]  T. Seiler,et al.  Manifest diabetes and keratoconus: A retrospective case-control study , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[14]  T. Seiler,et al.  Collagen Fiber Diameter in the Rabbit Cornea After Collagen Crosslinking by Riboflavin/UVA , 2004, Cornea.

[15]  G. Wollensak,et al.  Behandlung von Keratokonus durch Kollagenvernetzung , 2003, Der Ophthalmologe.

[16]  T. Seiler,et al.  Stress‐strain measurements of human and porcine corneas after riboflavin–ultraviolet‐A‐induced cross‐linking , 2003, Journal of cataract and refractive surgery.

[17]  T. Seiler,et al.  Endothelial cell damage after riboflavin–ultraviolet‐A treatment in the rabbit , 2003, Journal of cataract and refractive surgery.

[18]  J. Zuclich,et al.  Ultraviolet-induced photochemical damage in ocular tissues. , 1989, Health physics.

[19]  Theo Seiler,et al.  Thermomechanical Behavior of Collagen-Cross-Linked Porcine Cornea , 2004, Ophthalmologica.

[20]  Alexander Podskochy,et al.  Protective role of corneal epithelium against ultraviolet radiation damage. , 2004, Acta ophthalmologica Scandinavica.

[21]  H. Kaufman.  Strengthening the cornea. , 2004, Cornea.

[22]  P. Riesz,et al.  A STUDY OF THE PHOTODYNAMIC EFFICIENCIES OF SOME EYE LENS CONSTITUENTS , 1991, Photochemistry and photobiology.

[23]  E. Spoerl,et al.  [Enzymatic evidence of the depth dependence of stiffening on riboflavin/UVA treated corneas]. , 2005, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[24]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.

[25]  Theo Seiler,et al.  Increased resistance of crosslinked cornea against enzymatic digestion , 2004, Current eye research.

[26]  E. Spörl,et al.  Collagen Crosslinking by Combined Riboflavin/Ultraviolet–A (UVA) Treatment can stop the progression of Keratoconus , 2004 .

[27]  G. Vrensen,et al.  The specific architecture of the anterior stroma accounts for maintenance of corneal curvature , 2001, The British journal of ophthalmology.